Merck & Co Inc (NYSE:MRK)
| 105.88 Delayed Data As of Sep 25 |  +0.04 / +0.04%Today’s Change | 85.29 Today|||52-Week Range 119.65 | -4.57% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 105.84 |
| Today’s open | 106.21 |
| Day’s range | 105.13 - 106.24 |
| Volume | 100 |
| Average volume (3 months) | 7,263,771 |
| Market cap | $269.8B |
Data as of 4:00pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | +11.18% |
| Earnings growth (this year) | -58.25% |
| Earnings growth (next 5 years) | +7.72% |
| Revenue growth (last year) | +19.56% |
| P/E ratio | 86.8 |
| Price/Sales | 4.82 |
| Price/Book | 5.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.05 | +0.03% |
| NONOFNovo Nordisk | -0.86 | -0.92% |
| AZNAstraZeneca | +1.11 | +1.64% |
| NVSNovartis | +0.67 | +0.66% |
Data as of 4:00pm ET, 09/25/2023
Financials
| Next reporting date | October 26, 2023 |
| EPS forecast (this quarter) | $1.96 |
| Annual revenue (last year) | $58.5B |
| Annual profit (last year) | $14.5B |
| Net profit margin | 24.83% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
